Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
- PMID: 11569897
- DOI: 10.1007/s004150170114
Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
Abstract
Recently an increased echogenicity of the substantia nigra (SN) in patients with Parkinson's disease (PD) was demonstrated by transcranial ultrasound (TCS). In this study we set out to compare SN echogenicitiy with disease characteristics (time of onset, duration, toxin exposure) in a large patients sample. Patients' history and exposure to toxins were recorded from 112 PD patients who underwent a thorough neurological examination including assessment of disease stage according to Hoehn and Yahr and CURS (Columbia University Rating Scale). Personality was assessed according to the Freiburg Personality Inventory. In all patients the area of SN echogenicity was encircled and measured by TCS. All except 9 patients had hyperechogenic SN areas exceeding the mean plus standard deviation values of an age matched control group (0.19 cm2). The age of disease onset was lower in patients who displayed an area of SN echogenicity above this value. The area of SN echogenicity was larger contralateral to the side with more severe symptoms. None of the other characteristics correlated with ultrasound findings. We conclude that SN hyperechogenicity is a typical finding in PD. The cause of hyperechogenicity is so far unknown. Investigation of the underlying reason might disclose a pathogenic factor in PD.
Similar articles
-
Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.Ultrasound Med Biol. 2019 Jan;45(1):122-128. doi: 10.1016/j.ultrasmedbio.2018.09.018. Epub 2018 Oct 26. Ultrasound Med Biol. 2019. PMID: 30482710
-
Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.Brain. 2007 Jul;130(Pt 7):1799-807. doi: 10.1093/brain/awm017. Epub 2007 Feb 28. Brain. 2007. PMID: 17329323
-
Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.J Parkinsons Dis. 2018;8(2):333-340. doi: 10.3233/JPD-171264. J Parkinsons Dis. 2018. PMID: 29614699
-
Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.J Neural Transm (Vienna). 2011 Apr;118(4):607-12. doi: 10.1007/s00702-010-0564-7. Epub 2010 Dec 29. J Neural Transm (Vienna). 2011. PMID: 21190047 Review.
-
Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.J Neural Transm (Vienna). 2011 Mar;118(3):453-61. doi: 10.1007/s00702-010-0469-5. Epub 2010 Sep 10. J Neural Transm (Vienna). 2011. PMID: 20830493 Review.
Cited by
-
Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.Neurol Sci. 2013 Jun;34(6):935-40. doi: 10.1007/s10072-012-1164-0. Epub 2012 Jul 28. Neurol Sci. 2013. PMID: 22843227
-
How should we be using biomarkers in trials of disease modification in Parkinson's disease?Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265. Brain. 2023. PMID: 37536279 Free PMC article.
-
Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.PLoS One. 2013;8(2):e56438. doi: 10.1371/journal.pone.0056438. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418568 Free PMC article.
-
Biomarkers of Parkinson's disease: current status and future perspectives.Drug Discov Today. 2013 Feb;18(3-4):155-62. doi: 10.1016/j.drudis.2012.09.001. Epub 2012 Sep 11. Drug Discov Today. 2013. PMID: 22982303 Free PMC article. Review.
-
Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.J Neurol. 2006 Apr;253(4):448-54. doi: 10.1007/s00415-005-0023-9. Epub 2005 Nov 4. J Neurol. 2006. PMID: 16267638
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical